---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-050753"
form_type: "8-K"
ticker: "OPRX"
cik: "0001448431"
company_name: "OptimizeRx Corp"
filed_at: "2024-06-07T23:59:59+00:00"
generated_at: "2026-06-01T05:32:03.040121+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# OptimizeRx shareholders approve 1.95M share increase to equity plan at annual meeting

## Summary
- Shareholders approved amendment to 2021 Equity Plan increasing share pool from 2.5M to 4.45M shares (increase of 1.95M).
- Equity plan vote: 10,129,247 for, 3,425,566 against, 8,853 abstain, 1,966,973 broker non-votes.
- All six director nominees elected; advisory say-on-pay approved with 8,790,190 for votes.
- UHY LLP ratified as independent auditor for fiscal 2024 with 13,628,263 votes for, 24,012 against, 1,878,364 abstain.

## SEC filing metadata
- accession: 0001213900-24-050753
- form_type: 8-K
- ticker: OPRX
- cik: 0001448431
- company_name: OptimizeRx Corp
- filed_at: 2024-06-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1448431/000121390024050753/0001213900-24-050753-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1448431/000121390024050753/ea0207524-8k_optimize.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-050753
- JSON: https://secwatch.observer/filing/0001213900-24-050753.json
- Plain text: https://secwatch.observer/filing/0001213900-24-050753.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.